Umibecestat HCl structure
|
Common Name | Umibecestat HCl | ||
|---|---|---|---|---|
| CAS Number | 2365306-62-1 | Molecular Weight | 586.7168 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H17Cl3F7N5O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Umibecestat HClUmibecestat, also known as CNP-520, is a beta-secretase inhibitor and is a drug candidate for prevention trials in Alzheimer's disease. CNP520 has a selectivity, pharmacodynamics, and distribution profile suitable for AD prevention studies. CNP520 reduced brain and cerebrospinal fluid (CSF) Aβ in rats and dogs, and Aβ plaque deposition in APP-transgenic mice. CNP520 reduces Aβ load and neuroinflammation in APP‐transgenic mice |
| Name | Umibecestat HCl |
|---|
| Description | Umibecestat, also known as CNP-520, is a beta-secretase inhibitor and is a drug candidate for prevention trials in Alzheimer's disease. CNP520 has a selectivity, pharmacodynamics, and distribution profile suitable for AD prevention studies. CNP520 reduced brain and cerebrospinal fluid (CSF) Aβ in rats and dogs, and Aβ plaque deposition in APP-transgenic mice. CNP520 reduces Aβ load and neuroinflammation in APP‐transgenic mice |
|---|
| Molecular Formula | C19H17Cl3F7N5O2 |
|---|---|
| Molecular Weight | 586.7168 |